Evolution of Alzheimer's Disease Cerebrospinal Fluid Biomarkers in Early Parkinson's Disease-Reference-Cited by-同舟云学术

Evolution of Alzheimer's Disease Cerebrospinal Fluid Biomarkers in Early Parkinson's Disease

Published:2020-07-02 Issue:3 Volume:88 Page:574-587
ISSN:0364-5134
Container-title:Annals of Neurology
language:en
Short-container-title:Ann Neurol

Author:

Irwin David J.¹^ORCID,Fedler Janel²,Coffey Christopher S.²,Caspell‐Garcia Chelsea²,Kang Ju Hee³,Simuni Tanya⁴,Foroud Tatiana⁵,Toga Arthur W.⁶,Tanner Caroline M.⁷,Kieburtz Karl⁸,Chahine Lana M.⁹,Reimer Alyssa¹⁰,Hutten Samantha¹⁰,Weintraub Daniel¹¹¹¹²^ORCID,Mollenhauer Brit¹³,Galasko Douglas R.¹⁴,Siderowf Andrew¹,Marek Kenneth¹⁵,Trojanowski John Q.¹⁶¹⁷,Shaw Leslie M.¹⁶,

Affiliation:

1. Department of NeurologySchool of Medicine at the University of Pennsylvania Philadelphia PA USA

2. Department of BiostatisticsCollege of Public Health, University of Iowa Iowa City IA USA

3. Department of Pharmacology & Clinical PharmacologyInha University Incheon South Korea

4. Feinberg School of MedicineNorthwestern University Chicago IL USA

5. Department of Medical and Molecular GeneticsIndiana University Indianapolis IN USA

6. Laboratory of Neuro ImagingUniversity of Southern California Los Angeles CA USA

7. Department of NeurologyUniversity of California San Francisco San Francisco CA USA

8. Department of NeurologyUniversity of Rochester Medical Center Rochester NY USA

9. Department of NeurologyUniversity of Pittsburgh Pittsburgh PA USA

10. The Michael J. Fox Foundation New York NY USA

11. Department of Psychiatry PerelmanSchool of Medicine at the University of Pennsylvania Philadelphia PA USA

12. Michael J. Crescenz VA Medical Center, Parkinson's Disease Research, Education, and Clinical Center Philadelphia PA USA

13. Department of NeurologyUniversity Medical Center, Göttingen Paracelsus‐Elena‐Klinik Kassel Germany

14. Department of NeurologyUniversity of San Diego San Diego CA USA

15. Institute for Neurodegenerative Disorders New Haven CT USA

16. Department of Pathology and Laboratory MedicineSchool of Medicine at the University of Pennsylvania Philadelphia PA USA

17. Center for Neurodegenerative Disease ResearchSchool of Medicine at the University of Pennsylvania Philadelphia PA USA

Funder

Michael J. Fox Foundation for Parkinson's Research

National Institutes of Health

Publisher

Wiley

Subject

Neurology (clinical),Neurology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ana.25811

Reference50 articles.

1. Neuropathologic substrates of Parkinson disease dementia

2. Neuropathological and genetic correlates of survival and dementia onset in synucleinopathies: a retrospective analysis

3. CSF amyloid 1-42 predicts cognitive decline in Parkinson disease

4. CSF Aβ42and tau in Parkinson's disease with cognitive impairment

5. CSF amyloid- and tau proteins, and cognitive performance, in early and untreated Parkinson's Disease: the Norwegian ParkWest study

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The association of CSF biomarkers and cognitive decline with choroid plexus volume in early Parkinson's disease;Parkinsonism & Related Disorders;2024-03

2. Evaluation of ATN _PD Framework and Biofluid Markers to Predict Cognitive Decline in Early Parkinson Disease;Neurology;2024-02

3. Parkinson’s Progression Markers Initiative: A Milestone-Based Strategy to Monitor Parkinson’s Disease Progression;Journal of Parkinson's Disease;2023-09-08

4. IgG index of cerebrospinal fluid can reflect pathophysiology associated with Lewy bodies in Parkinson's disease;Journal of the Neurological Sciences;2023-09

5. Evolution and Predictive Role of Plasma Alzheimer’s Disease-related Pathological Biomarkers in Parkinson’s Disease;The Journals of Gerontology: Series A;2023-08-10